Recommendation ID
NG245/3
Question

What is the cost-effectiveness and feasibility of the proposed BTS/NICE/SIGN diagnostic pathways for asthma in children and young people aged 5 and over and in adults aged 17 and over?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale and impact section on objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma .

Full details of the evidence and the committee's discussion are in:

evidence review A: diagnostic test accuracy of spirometry in people suspected of asthma

evidence review B: diagnostic test accuracy for bronchodilator reversibility in people suspected of asthma

evidence review C: diagnostic test accuracy of peak expiratory flow variability for the diagnosis of asthma

evidence review D: accuracy of skin prick test in children for the diagnosis of asthma

evidence review E: diagnostic test accuracy of IgE in children

evidence review F: diagnostic accuracy of fractional exhaled nitric oxide (FeNO) measures

evidence review G: diagnostic accuracy of eosinophil blood count measures in the diagnosis of asthma

evidence review H: bronchial challenge with histamine and methacholine for the diagnosis of asthma

evidence review I: bronchial challenge test with mannitol

evidence review J: bronchial challenge testing in response to exercise for the diagnosis of asthma

evidence review K: diagnostic accuracy of combination of tests.


Source guidance details

Comes from guidance
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)
Number
NG245
Date issued
November 2024

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 28/01/2025